{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:57:23Z","timestamp":1773921443775,"version":"3.50.1"},"posted":{"date-parts":[[2026,3,16]]},"group-title":"Microbiology","reference-count":69,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH","award":["1ZIAAI001125-04"],"award-info":[{"award-number":["1ZIAAI001125-04"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,3,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>TRIpartite Motif (TRIM) protein 5 alpha (TRIM5\u03b1) is a well characterized cellular inhibitor of lentivirus replication that limits transmission of related viruses between primates. We previously reported that TRIM5\u03b1 derived from humans and rhesus macaques inhibits replication of orthoflaviviruses belonging to the tick-borne encephalitis virus (TBEV) serocomplex, including TBEV, Kyasanur forest disease virus and Langat virus (LGTV), but interestingly not the tick-borne Powassan virus (POWV). To further characterize the primate TRIM5\u03b1 and orthoflavivirus interface, we screened TRIM5\u03b1 variants from representative old- and new-world primates for restriction capacity. TRIM5\u03b1 from old-world African green monkey, De Brazza\u2019s monkey and chimpanzee demonstrated virus-specific restriction of tick-borne orthoflaviviruses. Efforts to determine why TRIM5\u03b1 fails to inhibit POWV revealed that our lab stock had acquired a non-synonymous mutation in NS3 that, when introduced into a POWV molecular clone, facilitated virus replication in the presence of all inhibitory primate TRIM5\u03b1 proteins. Infection of human dendritic cells with TRIM5\u03b1-resistant POWV resulted in high early replication and strong induction of interferon responses that limited replication compared with the wild-type virus. Thus, primate TRIM5\u03b1 functions as a potent cellular barrier to infection with tick-borne orthoflaviviruses that restrains replication to a level that may help avoid early innate immune recognition.<\/jats:p>","DOI":"10.64898\/2026.03.15.711935","type":"posted-content","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T03:30:11Z","timestamp":1773718211000},"source":"Crossref","is-referenced-by-count":0,"title":["Restraint of Powassan virus replication by TRIM5\u03b1 facilitates viral avoidance of antiviral immunity"],"prefix":"10.64898","author":[{"given":"Rebecca M.","family":"Broeckel","sequence":"first","affiliation":[{"name":"Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily A.","family":"Fitzmeyer","sequence":"additional","affiliation":[{"name":"Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Chebishev","sequence":"additional","affiliation":[{"name":"Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey G.","family":"Shannon","sequence":"additional","affiliation":[{"name":"Innate Immunity and Pathogenesis Section, Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byron","family":"Shue","sequence":"additional","affiliation":[{"name":"Innate Immunity and Pathogenesis Section, Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Hage","sequence":"additional","affiliation":[{"name":"Innate Immunity and Pathogenesis Section, Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Spada","sequence":"additional","affiliation":[{"name":"Innate Immunity and Pathogenesis Section, Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA"},{"name":"Molecular Parasitology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efrosini","family":"Artikis","sequence":"additional","affiliation":[{"name":"TSE\/Prion Biochemistry Section, Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhilash I.","family":"Chiramel","sequence":"additional","affiliation":[{"name":"Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin L.","family":"McNally","sequence":"additional","affiliation":[{"name":"Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles L.","family":"Larson","sequence":"additional","affiliation":[{"name":"Innate Immunity and Pathogenesis Section, Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarit","family":"von Kutzleben","sequence":"additional","affiliation":[{"name":"Innate Immunity and Pathogenesis Section, Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelly J.","family":"Robertson","sequence":"additional","affiliation":[{"name":"Innate Immunity and Pathogenesis Section, Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle K.","family":"Offerdahl","sequence":"additional","affiliation":[{"name":"Biology of Vector-Borne Viruses Section, Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary A.","family":"Lakin","sequence":"additional","affiliation":[{"name":"Innate Immunity and Pathogenesis Section, Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marshall E.","family":"Bloom","sequence":"additional","affiliation":[{"name":"Biology of Vector-Borne Viruses Section, Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod","family":"Nair","sequence":"additional","affiliation":[{"name":"Reserch Technologies Section, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas S.","family":"Eyre","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Adelaide, Adelaide, SA, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Beard","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Adelaide, Adelaide, SA, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Grigg","sequence":"additional","affiliation":[{"name":"Molecular Parasitology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadila","family":"Bouamr","sequence":"additional","affiliation":[{"name":"Molecular Parasitology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0206-297X","authenticated-orcid":false,"given":"Sonja M.","family":"Best","sequence":"additional","affiliation":[{"name":"Innate Immunity and Pathogenesis Section, Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026031900250586000_2026.03.15.711935v1.1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","article-title":"The continued threat of emerging flaviviruses","volume":"5","year":"2020","journal-title":"Nat Microbiol"},{"key":"2026031900250586000_2026.03.15.711935v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.03.032"},{"key":"2026031900250586000_2026.03.15.711935v1.3","doi-asserted-by":"crossref","unstructured":"O. Campbell , P. J. Krause , The emergence of human Powassan virus infection in North America. Ticks Tick Borne Dis 11, 101540 (2020).","DOI":"10.1016\/j.ttbdis.2020.101540"},{"key":"2026031900250586000_2026.03.15.711935v1.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-019-0225-2"},{"key":"2026031900250586000_2026.03.15.711935v1.5","doi-asserted-by":"publisher","DOI":"10.1038\/nature02343"},{"key":"2026031900250586000_2026.03.15.711935v1.6","doi-asserted-by":"publisher","DOI":"10.1038\/nature09976"},{"key":"2026031900250586000_2026.03.15.711935v1.7","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019103958"},{"key":"2026031900250586000_2026.03.15.711935v1.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-009-0358-y"},{"key":"2026031900250586000_2026.03.15.711935v1.9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409853102"},{"key":"2026031900250586000_2026.03.15.711935v1.10","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1038\/s41564-022-01247-0","article-title":"Evasion of cGAS and TRIM5 defines pandemic HIV","volume":"7","year":"2022","journal-title":"Nat Microbiol"},{"key":"2026031900250586000_2026.03.15.711935v1.11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009678"},{"key":"2026031900250586000_2026.03.15.711935v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.05.040"},{"key":"2026031900250586000_2026.03.15.711935v1.13","first-page":"89","article-title":"Vaccination of human volunteers against Russian spring-summer (RSS) virus complex with attenuated Langat E5 virus","volume":"42","year":"1970","journal-title":"Bull World Health Organ"},{"key":"2026031900250586000_2026.03.15.711935v1.14","doi-asserted-by":"crossref","unstructured":"Y. X. Setoh et al., De Novo Generation and Characterization of New Zika Virus Isolate Using Sequence Data from a Microcephaly Case. mSphere 2, (2017).","DOI":"10.1128\/mSphereDirect.00190-17"},{"key":"2026031900250586000_2026.03.15.711935v1.15","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3179"},{"key":"2026031900250586000_2026.03.15.711935v1.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2011.08.004"},{"key":"2026031900250586000_2026.03.15.711935v1.17","doi-asserted-by":"publisher","DOI":"10.1086\/657418"},{"key":"2026031900250586000_2026.03.15.711935v1.18","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13365-023-01182-8","article-title":"Genetic polymorphisms in innate immunity genes influence predisposition to tick-borne encephalitis","volume":"29","year":"2023","journal-title":"J Neurovirol"},{"key":"2026031900250586000_2026.03.15.711935v1.19","doi-asserted-by":"crossref","unstructured":"C. Panayiotou et al., Viperin Restricts Zika Virus and Tick-Borne Encephalitis Virus Replication by Targeting NS3 for Proteasomal Degradation. J Virol 92, (2018).","DOI":"10.1128\/JVI.00501-18"},{"key":"2026031900250586000_2026.03.15.711935v1.20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011286"},{"key":"2026031900250586000_2026.03.15.711935v1.21","doi-asserted-by":"publisher","DOI":"10.1086\/497340"},{"key":"2026031900250586000_2026.03.15.711935v1.22","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3123"},{"key":"2026031900250586000_2026.03.15.711935v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0391-5"},{"key":"2026031900250586000_2026.03.15.711935v1.24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302110"},{"key":"2026031900250586000_2026.03.15.711935v1.25","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41586-023-06401-0","article-title":"TRIM5alpha restricts poxviruses and is antagonized by CypA and the viral protein C6","volume":"620","year":"2023","journal-title":"Nature"},{"key":"2026031900250586000_2026.03.15.711935v1.26","doi-asserted-by":"crossref","unstructured":"S. J. Spada , M. E. Grigg , F. Bouamr , S. M. Best , P. Zhang , TRIM5alpha: A Protean Architect of Viral Recognition and Innate Immunity. Viruses 16, (2024).","DOI":"10.3390\/v16070997"},{"key":"2026031900250586000_2026.03.15.711935v1.27","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03033-15"},{"key":"2026031900250586000_2026.03.15.711935v1.28","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02496-15"},{"key":"2026031900250586000_2026.03.15.711935v1.29","doi-asserted-by":"crossref","unstructured":"Z. Lukic et al., TRIM5alpha associates with proteasomal subunits in cells while in complex with HIV-1 virions. Retrovirology 8, 93 (2011).","DOI":"10.1186\/1742-4690-8-93"},{"key":"2026031900250586000_2026.03.15.711935v1.30","doi-asserted-by":"publisher","DOI":"10.4161\/15548627.2014.984278"},{"key":"2026031900250586000_2026.03.15.711935v1.31","doi-asserted-by":"crossref","first-page":"e1009017","DOI":"10.1371\/journal.ppat.1009017","article-title":"A non-canonical role for the autophagy machinery in anti-retroviral signaling mediated by TRIM5alpha","volume":"16","year":"2020","journal-title":"PLoS Pathog"},{"key":"2026031900250586000_2026.03.15.711935v1.32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1203536109"},{"key":"2026031900250586000_2026.03.15.711935v1.33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005085"},{"key":"2026031900250586000_2026.03.15.711935v1.34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003352"},{"key":"2026031900250586000_2026.03.15.711935v1.35","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.14.8870-8877.2005"},{"key":"2026031900250586000_2026.03.15.711935v1.36","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.14.8969-8978.2005"},{"key":"2026031900250586000_2026.03.15.711935v1.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2004.12.042"},{"key":"2026031900250586000_2026.03.15.711935v1.38","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.18.11580-11587.2005"},{"key":"2026031900250586000_2026.03.15.711935v1.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2020.12.007"},{"key":"2026031900250586000_2026.03.15.711935v1.40","doi-asserted-by":"crossref","first-page":"e1688","DOI":"10.1002\/wrna.1688","article-title":"Conserved motifs in the flavivirus NS3 RNA helicase enzyme","volume":"13","year":"2022","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"2026031900250586000_2026.03.15.711935v1.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2013.07.025"},{"key":"2026031900250586000_2026.03.15.711935v1.42","doi-asserted-by":"publisher","DOI":"10.1021\/bi4014962"},{"key":"2026031900250586000_2026.03.15.711935v1.43","doi-asserted-by":"crossref","unstructured":"D. Morger et al., The Three-Fold Axis of the HIV-1 Capsid Lattice Is the Species-Specific Binding Interface for TRIM5alpha. J Virol 92, (2018).","DOI":"10.1128\/JVI.01541-17"},{"key":"2026031900250586000_2026.03.15.711935v1.44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1210903109"},{"key":"2026031900250586000_2026.03.15.711935v1.45","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.058180-0"},{"key":"2026031900250586000_2026.03.15.711935v1.46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1013426108"},{"key":"2026031900250586000_2026.03.15.711935v1.47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1402448111"},{"key":"2026031900250586000_2026.03.15.711935v1.48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1318962111"},{"key":"2026031900250586000_2026.03.15.711935v1.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2018.10.007"},{"key":"2026031900250586000_2026.03.15.711935v1.50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12388-y"},{"key":"2026031900250586000_2026.03.15.711935v1.51","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.090936"},{"key":"2026031900250586000_2026.03.15.711935v1.52","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2016.1265192"},{"key":"2026031900250586000_2026.03.15.711935v1.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2014.08.004"},{"key":"2026031900250586000_2026.03.15.711935v1.54","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.6.2913-2923.2006"},{"key":"2026031900250586000_2026.03.15.711935v1.55","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00176-10"},{"key":"2026031900250586000_2026.03.15.711935v1.56","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-43-1-247"},{"key":"2026031900250586000_2026.03.15.711935v1.57","doi-asserted-by":"crossref","unstructured":"E. T. Stone , A. J. Hirsch , J. L. Smith , J. D. Brien , A. K. Pinto , Titration and neutralizing antibody quantification by focus forming assay for Powassan virus. STAR Protoc 3, 101473 (2022).","DOI":"10.1016\/j.xpro.2022.101473"},{"key":"2026031900250586000_2026.03.15.711935v1.58","doi-asserted-by":"crossref","first-page":"e0346823","DOI":"10.1128\/mbio.03468-23","article-title":"Recapitulation of the Powassan virus life cycle in cell culture","volume":"15","year":"2024","journal-title":"mBio"},{"key":"2026031900250586000_2026.03.15.711935v1.59","doi-asserted-by":"crossref","unstructured":"E. H. Klontz et al., Analysis of Powassan Virus Genome Sequences from Human Cases Reveals Substantial Genetic Diversity with Implications for Molecular Assay Development. Viruses 16, (2024).","DOI":"10.3390\/v16111653"},{"key":"2026031900250586000_2026.03.15.711935v1.60","doi-asserted-by":"crossref","first-page":"ofaa392","DOI":"10.1093\/ofid\/ofaa392","article-title":"Powassan Virus Neuropathology and Genomic Diversity in Patients With Fatal Encephalitis","volume":"7","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2026031900250586000_2026.03.15.711935v1.61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012206"},{"key":"2026031900250586000_2026.03.15.711935v1.62","doi-asserted-by":"crossref","unstructured":"P. Bastard et al., Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine. J Exp Med 218, (2021).","DOI":"10.1084\/jem.20202486"},{"key":"2026031900250586000_2026.03.15.711935v1.63","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2789"},{"key":"2026031900250586000_2026.03.15.711935v1.64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012561"},{"key":"2026031900250586000_2026.03.15.711935v1.65","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts635"},{"key":"2026031900250586000_2026.03.15.711935v1.66","doi-asserted-by":"crossref","unstructured":"B. Li , C. N. Dewey , RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).","DOI":"10.1186\/1471-2105-12-323"},{"key":"2026031900250586000_2026.03.15.711935v1.67","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007"},{"key":"2026031900250586000_2026.03.15.711935v1.68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"2026031900250586000_2026.03.15.711935v1.69","doi-asserted-by":"publisher","DOI":"10.1093\/NAR\/GKAD1025"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.03.15.711935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:25:17Z","timestamp":1773905117000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.03.15.711935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":69,"URL":"https:\/\/doi.org\/10.64898\/2026.03.15.711935","relation":{},"subject":[],"published":{"date-parts":[[2026,3,16]]},"subtype":"preprint"}}